Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling with tranexamic acid plus hydroquinone vs either alone for melasma
IRCT20220122053789N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid and hydroquinone in melasma (3 arms), sponsored by Iran University of Medical Sciences. Started Mar 2022; status: completed.
02
Drugs
tranexamic acidhydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20220122053789N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220122053789N1.